Search

Search Constraints

You searched for: Author/Creator Subocz, Edyta

Search Results

1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Issue 2 (1st October 2022)

2. Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium. Issue 3 (23rd February 2020)

3. Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival. Issue 8 (20th November 2020)

4. Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Issue 2 (February 2015)

5. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients. Issue 2 (30th March 2021)

6. Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*. Issue 2 (28th January 2019)

7. Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group. Issue 2 (28th January 2019)

8. Hodgkin lymphoma transformation of chronic lymphocytic leukemia—A real life data from the Polish Lymphoma Research Group. Issue 4 (14th June 2019)

9. Identification of miRSNPs associated with the risk of multiple myeloma. Issue 3 (9th November 2016)

10. Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study 'PolAZA'. Issue 1 (1st January 2021)